Clinical use of pre-emptive pharmacogenetic programmes

A 12-gene pharmacogenetic panel to prevent adverse drug reactions: an open-label, multicentre, controlled, cluster-randomised crossover implementation study

(2023) Jesse J Swen et al.   LANCET

A one-year follow-up study of treatment-compliant suicide attempt survivors: relationship of CYP2D6-CYP2C19 and polypharmacy with suicide reattempts

(2022) Eva M. Peñas-Lledó et al.   Translational Psychiatry

Clinical impact of pharmacogenetic profiling with a clinical decision support tool in polypharmacy home health patients: A prospective pilot randomized controlled trial

(2017) Lindsay S. Elliott et al.   PLoS One

CYP450 genotype and pharmacogenetic association studies: a critical appraisal

(2016) Rashmi R Shah et al.   PHARMACOGENOMICS

The effect of pharmacogenetic profiling with a clinical decision support tool on healthcare resource utilization and estimated costs in the elderly exposed to polypharmacy

(2015) D. Brixner et al.   JOURNAL OF MEDICAL ECONOMICS

CYP2D6 variation, behaviour and psychopathology: implications for pharmacogenomics-guided clinical trials

(2013) Eva M. Peñas-LLedó et al.   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY